alpha-aminopyridine has been researched along with Parkinsonian Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, JS; Hou, L; Jing, L; Li, S; Peng, B; Ruan, Z; Wang, Q; Zhang, D; Zhang, X; Zhao, J | 1 |
| Blokland, A; Heckman, PRA; Prickaerts, J; Van Goethem, NP; Van Hagen, BTJ | 1 |
| Ali, U; Liu, J; Liu, X; Wang, S; Wang, T; Wu, ZH; Zhang, QJ | 1 |
3 other study(ies) available for alpha-aminopyridine and Parkinsonian Disorders
| Article | Year |
|---|---|
Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson's disease model.
Topics: Aminopyridines; Animals; Cognitive Dysfunction; Insecticides; Male; Mice; Mice, Inbred C57BL; Microglia; Minocycline; Parkinsonian Disorders; Pyrroles; Rotenone | 2021 |
The mediating role of phosphodiesterase type 4 in the dopaminergic modulation of motor impulsivity.
Topics: Aminopyridines; Animals; Benzamides; Brain; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Dextroamphetamine; Dopamine; Dopamine Uptake Inhibitors; Impulsive Behavior; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Phosphodiesterase 4 Inhibitors; Rats, Wistar | 2018 |
Subthalamic neurons show increased firing to 5-HT2C receptor activation in 6-hydroxydopamine-lesioned rats.
Topics: Action Potentials; Aminopyridines; Analysis of Variance; Animals; Immunohistochemistry; Indoles; Male; Microelectrodes; Neurons; Oxidopamine; Parkinsonian Disorders; Piperazines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Receptor Agonists; Substantia Nigra; Subthalamic Nucleus | 2009 |